Company Registration No. 08799165 (England and Wales)
OLIVE PHARMA LIMITED
Unaudited accounts
for the year ended 31 March 2025
OLIVE PHARMA LIMITED
Unaudited accounts
Contents
OLIVE PHARMA LIMITED
Company Information
for the year ended 31 March 2025
Company Number
08799165 (England and Wales)
Registered Office
50 Highfield Lane
Keighley
BD21 2EH
United Kingdom
OLIVE PHARMA LIMITED
Statement of financial position
as at 31 March 2025
Intangible assets
228,867
250,232
Tangible assets
151,310
175,081
Cash at bank and in hand
33,120
152,392
Creditors: amounts falling due within one year
(279,984)
(539,011)
Net current assets
525,272
556,937
Net assets
905,449
982,250
Called up share capital
100
100
Share premium
152,400
152,400
Profit and loss account
752,949
829,750
Shareholders' funds
905,449
982,250
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 December 2025 and were signed on its behalf by
Atiq Saddique
Director
Company Registration No. 08799165
OLIVE PHARMA LIMITED
Notes to the Accounts
for the year ended 31 March 2025
OLIVE PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 08799165. The registered office is 50 Highfield Lane, Keighley, BD21 2EH, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
4
Intangible fixed assets
Total
Charge for the year
21,365
OLIVE PHARMA LIMITED
Notes to the Accounts
for the year ended 31 March 2025
5
Tangible fixed assets
Total
Charge for the year
23,771
6
Average number of employees
During the year the average number of employees was 28 (2024: 28).